NCT00043147View on ClinicalTrials.gov

Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2002

Study Completion Date

January 31, 2005

Conditions
Graft Versus Host Disease
Interventions
DRUG

beclomethasone dipropionate

DRUG

methylprednisolone

DRUG

prednisone

Trial Locations (2)

10021

Memorial Sloan-Kettering Cancer Center, New York

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00043147 - Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease | Biotech Hunter | Biotech Hunter